
John McMurray
Articles
-
Jan 15, 2025 |
onthewater.com | John McMurray
Capt. McMurray is the owner of One More Cast Charters in Oceanside, NY. While there has been a lot going on with striped bass management over the last few years, I’ve only been tangentially involved. I no longer have a seat at the Atlantic States Marine Fisheries Commission (ASMFC) table, and I’m no longer associated with any fisheries advocacy group. For the most part, that’s intentional.
-
Dec 9, 2024 |
onthewater.com | John McMurray
It was December 16, 2001, and after a Scotch tasting at the Angler’s Club, I had fallen asleep (read: “passed out”) on the subway back to Rockaway. It was amazing I still had my wallet, not to mention my laptop, when I awoke somewhere in Brooklyn to my phone ringing. I tried to say hello, but my voice wasn’t yet working. “Where the hell are you?” said Capt. David Azar before I could speak. We were going to make one last go of it before pulling the boat and calling it a season.
-
Nov 8, 2024 |
saltwatersportsman.com | John McMurray
Topwater striper lure bites come when you least expect it. You’re fishing seemingly dead water, casting to a sod bank, or some other structure. Then out of nowhere, KABOOM! Your topwater fishing lure disappears in a ball of white water. It is violent, savage and truly magical at the same time. In my 25 plus years of guiding anglers for striped bass, I have yet to see anyone that didn’t get excited about seeing a nice striper smash a topwater lure.
-
Oct 15, 2024 |
radcliffecvrm.com | Mikhail Kosiborod |Maria Serova |Maria Chashkina |John McMurray
Video Published: Views: 44 Likes: 0 Average (ratings) HFSA 24 - We are joined virtually by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss findings from the STEP-HFpEF trial programme in regard to the efficacy of semaglutide according to frailty status, and exercise function at baseline. Interview Questions:1. Could you remind us of the importance of STEP-HFpEF2. What was the study design and patient population? 3.
-
Sep 27, 2024 |
radcliffecvrm.com | Helen M. Colhoun |John McMurray |Richard E. Pratley |Phyo T. Htoo
EASD 24 - We are joined by Dr Helen Coulhoun (University of Edinburgh, UK) to discuss the key findings of a prespecified analysis of the SELECT trial, which investigated the effectiveness of semaglutide in reducing major cardiac events in the presence of impaired kidney function in patients with overweight and obesity.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →